|
|
 |
 Trends in Study Design In bringing novel therapeutics to market, clinical development programs face intense pressures to meet speed and efficiency goals. Enter innovative adaptive study designs that enable modification of the clinical program, drawing from early efficacy readouts. Such approaches aim to avoid sunken costs and reallocate resources to the most viable candidate therapeutics or research questions of interest with the aim of accelerating the availability of efficacious treatments to patients. As a consequence, clinical study designs are gaining complexity to answer as many questions within a single study.
 |
|
|
|
|
|
|
 |
April 6, 2023 | 12:00pm - 4:00pm
AC Hotel by Marriott San Francisco Airport
Oyster Point Waterfront
South San Francisco, CA
|
|
 |
May 11, 2023 | 12:00pm - 4:00pm
Le Méridien Boston Cambridge
|
|
|
October 26, 2023 | 12:00pm - 4:00pm
Le Méridien Boston Cambridge
|
|
Why Attend VendorFest Cambridge |
 |
Discover the latest products and services from leading life science suppliers |
|
Improve your supply chain or service networks–or build new ones |
|
Network with more than 500 of your industry colleagues from the Boston/Cambridge area. |
|
Participate in Exhibit Hall Raffles |
|
Enjoy our OktoberFest Event with beer tasting, food, more! |
|
VendorFest is a no-cost event for drug discovery and development professionals |
|
|
|
|
|
 |
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab Cammett, Garlo, Millman et al
Mol Diagn Ther (2022)
 |
|
 |
Progress: Responsiveness Validation of an Electronic Patient Reported Outcome (ePRO) in Adults with Sickle Cell Disease (NCT05407805) Minniti, Bronte-Hall, Marraffino et al
Blood (2022) 140 (Supplement 1)
|
|
|
|
|
|
|
|
|
|
|
| To unsubscribe, click here. ©2023 Sanguine, 318 Bear Hill Road, Suite 1, Waltham, MA 02451
| https://sanguinebio.com |  | 818-462-8290 |
|
